Averto Medical Inc
Publicly observedFremont, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Fremont | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Averto Medical Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | QD1WD56LF265 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant19 Sept 2025Publicly observed
NIH SBIR/STTR award: Safety and Efficacy Trial of the ColoSeal ICD System for the Treatment of Diverticular Disease Patients
USD 1,192,362.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant20 Sept 2024Publicly observed
NIH SBIR/STTR award: Safety and Efficacy Trial of the ColoSeal ICD System for the Treatment of Rectal Cancer Patients
USD 928,967.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.